Pharmacology of Drugs related to Hypothalamic & Pituitary Hormones Flashcards
The effects of growth hormone are mediated by the production of what hormone?
Insulin-like growth factor 1 (IGF1)
This drug is a purified form of FSH.
Urofollitropin
What is the MOA of Pegvisomant?
Growth hormone receptor antagonist
These drugs act to inhibit growth hormone release.
Octreotide, lanreotide
This is a recombinant form of growth hormone.
Somatropin
This drug is an ADH analog that increases cofactor VIII & vWF.
Vasopressin
True/False. GnRH agonists cause an initial rise in LH & FSH release before inhibition.
True - LH & FSH are initially released before receptors are downregulated
These drugs are contradicted in patients with a history of psychosis.
D2 agonists - cabergoline, bromocriptine
Release of this hormone is inhibited by dopamine binding to D2 receptors.
Prolactin
True/False. Mecasermin is associated with hyperglycemia.
False - Mecasermin is associated with hypoglycemia since it mimics the action of insulin.
Somatropin is associated with hyperglycemia.
This drug is a recombinant form of LH.
Lutropin
What is the MOA of ganirelix and degarelix?
GnRH antagonists
What is the benefit of pegvisomant vs. octreotide?
Pegvisomant is specific to GH. Octreotide inhibits the release of GH, but also inhibits insulin, glucagon, and gastrin
This is a recombinant form of IGF-1.
Mecasermin